Details for Patent: 9,023,893
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 9,023,893 protect, and when does it expire?
Patent 9,023,893 protects TEKTURNA HCT and is included in one NDA.
This patent has ninety-three patent family members in thirty-one countries.
Summary for Patent: 9,023,893
Title: | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
Abstract: | The invention relates to a combination comprising the renin inhibitor of formula (I) ##STR00001## or a pharmaceutically acceptable salt thereof. |
Inventor(s): | Hewitt; William (Pottstown, PA), Vasella; Daniel L (Basel, CH), Webb; Randy L (Flemington, NJ) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 13/235,659 |
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 9,023,893
Foreign Priority and PCT Information for Patent: 9,023,893
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 0028151.9 | Nov 17, 2000 |
International Family Members for US Patent 9,023,893
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 317692 | See Plans and Pricing | |||
Austria | 397445 | See Plans and Pricing | |||
Australia | 2002223680 | See Plans and Pricing | |||
Australia | 2368002 | See Plans and Pricing | |||
Brazil | 0115411 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |